Ilias Goranitis
Overview
Explore the profile of Ilias Goranitis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
583
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelada L, Best S, Pierce K, Allen M, Cobb J, Berens K, et al.
Eur J Paediatr Neurol
. 2025 Feb;
54:147-158.
PMID: 39919518
Introduction: Patients with developmental and epileptic encephalopathies (DEEs) have multiple comorbidities and high healthcare needs. Whether health services meet the needs of this patient population and their families is not...
2.
Schilling C, Sjaaf F, Goranitis I, Dalziel K, Martyn M, Stark Z, et al.
Eur J Hum Genet
. 2025 Feb;
PMID: 39910329
The Australian government subsidises medical services, including several genetic and genomic tests, through a federal funding scheme. We explore trends and variation in the utilisation of the publicly funded genetic...
3.
Smith H, Regier D, Goranitis I, Bourke M, IJzerman M, Degeling K, et al.
Appl Health Econ Health Policy
. 2025 Jan;
PMID: 39832089
Introduction: Genomic medicine has features that make it preference sensitive and amenable to model-based health economic evaluation. Preferences of patients, caregivers, and clinicians related to the uptake and delivery of...
4.
Goranitis I, Sheen D, Fehlberg Z, Mallett A, Best S, Stark Z
Value Health
. 2024 Dec;
28(2):184-190.
PMID: 39725011
Objectives: The multifaceted ways in which genomics can be valuable to clinicians, patients, families, and society are important for informing prioritization decisions by policy makers. This study aims to develop...
5.
Santos Gonzalez F, Hock D, Thorburn D, Mordaunt D, Williamson N, Ang C, et al.
Orphanet J Rare Dis
. 2024 Nov;
19(1):443.
PMID: 39609890
Background: Mass spectrometry-based quantitative proteomics has a demonstrated utility in increasing the diagnostic yield of mitochondrial disorders (MDs) and other rare diseases. However, for this technology to be widely adopted...
6.
Fehlberg Z, Fisher L, Liu C, Kugenthiran N, Milne R, Young M, et al.
Eur J Hum Genet
. 2024 Nov;
33(1):108-120.
PMID: 39532988
As the possibility of implementing population genomic screening programs for the risk of developing hereditary cancers in health systems increases, understanding how to support individuals who wish to have genomic...
7.
Santos Gonzalez F, Ungar W, Buchanan J, Christodoulou J, Stark Z, Goranitis I
Genet Med
. 2024 Nov;
27(2):101310.
PMID: 39522058
No abstract available.
8.
Rius R, Compton A, Baker N, Balasubramaniam S, Best S, Bhattacharya K, et al.
Genet Med
. 2024 Sep;
27(1):101271.
PMID: 39305161
Purpose: Families living with mitochondrial diseases (MD) often endure prolonged diagnostic journeys and invasive testing, yet many remain without a molecular diagnosis. The Australian Genomics Mitochondrial Flagship, comprising clinicians, diagnostic,...
9.
Ride J, Goranitis I, Meng Y, LaBond C, Lancsar E
Pharmacoeconomics
. 2024 Sep;
42(10):1161-1175.
PMID: 39227559
Background: Reporting standards of discrete choice experiments (DCEs) in health have not kept pace with the growth of this method, with multiple reviews calling for better reporting to improve transparency,...
10.
Mallawaarachchi A, Biros E, Harris T, Bennetts B, Boughtwood T, Elliott J, et al.
Hum Genomics
. 2024 Aug;
18(1):88.
PMID: 39154021
The KidGen Collaborative's Policy Implementation Workshop 2023 celebrated the 10th anniversary of Australia's first kidney genetics clinic in Brisbane. This event marked the establishment of a national network now comprising...